1413TiP - LIBRETTO-431: Selpercatinib in treatment (Tx)-nave patients with RET fusion-positive (RET+) non-small cell lung cancer (NSCLC)
Selpercatinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: 1413TiP - LIBRETTO-431: Selpercatinib in treatment (Tx)-nave patients with RET fusion-positive (RET+) non-small cell lung cancer (NSCLC) ### Output: Selpercatinib